Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
Mara Kocho has been recommended as the next Managing Director (MD) of the North Eastern…
Air Marshal Ashutosh Dixit, Air Officer Commanding-in-Chief, Central Air Command, inaugurated the Indian Air Force…
Businessman Alix Didier Fils-Aime has been sworn in as Haiti's new prime minister, vowing to…
On November 12, 2024, the Defence Research and Development Organisation (DRDO) successfully conducted the maiden…
Law and Justice Minister Arjun Ram Meghwal launched a book titled ‘Maa-Mother’ in New Delhi,…
India is a country known for its vast geography, which includes mountains, deserts, rivers, and…